Company Filing History:
1 out of 42 
1 out of 5,076 
1 out of 208 
Years Active: 2023
Title: Caroline Costa Fejoz: Innovator in Viral Vector Technology
Introduction
Caroline Costa Fejoz is a prominent inventor based in Lyons, France. She has made significant contributions to the field of viral vector technology, particularly in the development of innovative solutions for gene therapy and immune modulation.
Latest Patents
Caroline holds a patent for the invention titled "Nipah virus envelope glycoprotein pseudotyped lentivirus." This invention relates to pseudotyped retrovirus-like particles or retroviral vectors that incorporate engineered envelope glycoproteins derived from a virus of the Paramyxoviridae family. These glycoproteins are fused to a cell targeting domain and a functional domain. The invention is particularly useful for selectively modulating the activity of specific subsets of immune cells, making it valuable for applications in gene therapy, immune therapy, and vaccination. Caroline has 1 patent to her name.
Career Highlights
Throughout her career, Caroline has worked with esteemed institutions such as École Normale Supérieure de Lyon and the Centre National de la Recherche Scientifique. Her work has been instrumental in advancing the understanding and application of viral vectors in therapeutic contexts.
Collaborations
Caroline has collaborated with notable colleagues, including Els Verhoeyen and François-Loïc Cosset. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Caroline Costa Fejoz is a trailblazer in the field of viral vector technology, with her groundbreaking patent paving the way for advancements in gene therapy and immune modulation. Her contributions continue to impact the scientific community and hold promise for future medical applications.